Fennec Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2018 - 2014
Period Ending	Jan '25 Jan 17, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2018 - 2014
Market Capitalization	219	400	341	145	245	167	Upgrade
Market Cap Growth	-31.65%	17.23%	135.62%	-40.90%	46.29%	-2.49%	Upgrade
Enterprise Value	207	418	334	120	203	148	Upgrade
Last Close Price	8.99	15.16	13.09	5.60	9.09	8.45	Upgrade
PS Ratio	2.77	14.25	164.24	-	1131.07	-	Upgrade
PB Ratio	-26.46	-26.06	-98.13	7.26	6.61	10.87	Upgrade
P/TBV Ratio	-	-	-	7.26	6.61	10.87	Upgrade
EV/Sales Ratio	2.92	14.88	160.94	-	935.98	-	Upgrade
Debt / Equity Ratio	-6.21	-2.66	-9.69	0.32	-	-	Upgrade
Asset Turnover	1.27	0.79	0.06	-	0.01	-	Upgrade
Inventory Turnover	2.22	0.92	-	-	-	-	Upgrade
Quick Ratio	7.16	2.92	5.49	12.76	12.93	6.01	Upgrade
Current Ratio	7.80	3.56	5.80	13.54	13.39	6.11	Upgrade
Return on Equity (ROE)	-	-	-359.22%	-77.36%	-88.46%	-76.99%	Upgrade
Return on Assets (ROA)	2.70%	-29.67%	-57.21%	-39.99%	-49.07%	-43.84%	Upgrade
Return on Capital (ROIC)	5.00%	-38.32%	-65.53%	-43.20%	-54.60%	-49.00%	Upgrade
Earnings Yield	-0.83%	-5.30%	-9.41%	-15.16%	-9.42%	-9.89%	Upgrade
FCF Yield	17.24%	-5.66%	-7.16%	-12.43%	-8.11%	-7.02%	Upgrade
Buyback Yield / Dilution	-2.34%	-1.14%	-1.03%	-9.71%	-19.14%	-5.04%	Upgrade
Total Shareholder Return	-2.34%	-1.14%	-1.03%	-9.71%	-19.14%	-5.04%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.